23 January - trading update
The AIM-listed medical products group has issued a positive trading update for the year to 31 December with sales exceeding pre-pandemic levels and being ahead of expectations. The group has also returned to profitability in the second half of the year. Revenues for the year are expected to be £11.3m, more than 20% higher than the previous year's figure of £9.1m, with sales for the second half expected to be 10% higher than the first half. The group also expects to report a modest adjusted pre-tax profit for the year . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
